Awakn Life Sciences Stock Price To Book

AWKNF Stock  USD 0.09  0.01  7.84%   
Awakn Life Sciences fundamentals help investors to digest information that contributes to Awakn Life's financial success or failures. It also enables traders to predict the movement of Awakn OTC Stock. The fundamental analysis module provides a way to measure Awakn Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Awakn Life otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Awakn Life Sciences OTC Stock Price To Book Analysis

Awakn Life's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current Awakn Life Price To Book

    
  4.19 X  
Most of Awakn Life's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Awakn Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

Based on the latest financial disclosure, Awakn Life Sciences has a Price To Book of 4.1918 times. This is 83.68% lower than that of the Healthcare sector and 30.6% lower than that of the Biotechnology industry. The price to book for all United States stocks is 55.92% higher than that of the company.

Did you try this?

Run USA ETFs Now

   

USA ETFs

Find actively traded Exchange Traded Funds (ETF) in USA
All  Next Launch Module

Awakn Fundamentals

About Awakn Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Awakn Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Awakn Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Awakn Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Awakn OTC Stock

Awakn Life financial ratios help investors to determine whether Awakn OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Awakn with respect to the benefits of owning Awakn Life security.